The latest announcement is out from Inspira Technologies Oxy BHN ( (IINN) ).
On March 13, 2025, Inspira Technologies announced receiving a Nasdaq notification regarding non-compliance with the minimum bid price requirement, as their share price was below $1.00 for 30 consecutive business days. The company has until September 8, 2025, to regain compliance by ensuring the share price meets or exceeds $1.00 for at least 10 consecutive business days. Inspira Technologies plans to monitor its share price and consider options to address the deficiency, while its shares remain listed on the Nasdaq Capital Market.
More about Inspira Technologies Oxy BHN
Inspira Technologies Oxy B.H.N. Ltd. is a company specializing in innovative respiratory support and diagnostic technologies. Their flagship product, the INSPIRA ART system, is designed to revolutionize critical care by allowing patients to remain awake during treatment while stabilizing oxygen levels without mechanical ventilation. The company also offers the FDA-cleared INSPIRA ART100 system for Cardiopulmonary Bypass procedures and is developing other products like the HYLA blood sensor for continuous blood monitoring.
YTD Price Performance: -26.95%
Average Trading Volume: 1,251,549
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $18.92M
For detailed information about IINN stock, go to TipRanks’ Stock Analysis page.